Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in J Diabetes Complications Retrieve available abstracts of 237 articles: HTML format

Single Articles

October 2025
1. CHRISTENSEN MMB, Hansen CS, Fleischer J, Senftleber N, et al
   The prevalence of diabetic neuropathy in Greenland and its association with Inuit genetic ancestry - a cross-sectional study.
   J Diabetes Complications. 2025;39:109179.
   PubMed     Abstract available
   
   
   
2. FRALICK M, Hojbjerg Lassen MC, Rangrej J, Asgari S, et al
   Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study.
   J Diabetes Complications. 2025;39:109144.
   PubMed     Abstract available
   
   
   
3. KYKKANEN E, Kaartinen I, Arponen O, Vuorlaakso M, et al
   Low imaging-detected muscle mass as a prognostic factor for overall and amputation-free survival in patients undergoing lower extremity amputation.
   J Diabetes Complications. 2025;39:109119.
   PubMed     Abstract available
   
   
   September 2025
4. CHEN KY, Chan HC, Chan CM
   Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.
   J Diabetes Complications. 2025;39:109178.
   PubMed     Abstract available
   
   
   
5. SAMBATARO M, Sambado L, Colardo M, Furlan A, et al
   Neuroinflammation and osteomyelitis in adults with Type 2 diabetes mellitus and peripheral neuropathy without and with foot lesions. What comes first?
   J Diabetes Complications. 2025;39:109176.
   PubMed     Abstract available
   
   
   
6. HOFFMANN K, Paczkowska A, Maggio V, Rizzo M, et al
   The cardiovascular-kidney-metabolic staging in type 2 diabetes: the clock starts ticking early.
   J Diabetes Complications. 2025;39:109177.
   PubMed     Abstract available
   
   
   
7. RIZK MA, El-Haggar SM, Ibrahim OM, Ghazi HA, et al
   Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trial.
   J Diabetes Complications. 2025;39:109175.
   PubMed     Abstract available
   
   
   
8. XIE Z, Liang Z, Zheng G, Cao W, et al
   A comparative analysis of cost-utility: Chiglitazar vs. sitagliptin in patients with type 2 diabetes in China.
   J Diabetes Complications. 2025;39:109174.
   PubMed     Abstract available
   
   
   
9. PATEL D, Shah AS, Magella B, Bahrainian M, et al
   High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis.
   J Diabetes Complications. 2025;39:109091.
   PubMed     Abstract available
   
   
   
10. FANG Y, Jing L, Zhu Y, Wang H, et al
    Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109162.
    PubMed     Abstract available
    
    
    August 2025
11. JOHNSON TM, Churilla JR
    Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999-2018.
    J Diabetes Complications. 2025;39:109159.
    PubMed     Abstract available
    
    
    
12. VAIDYA D, Yeboah-Kordieh Y, Howard M, Hugenschmidt CE, et al
    Sex specific associations of sex hormones with brain volumes and cerebral blood flow: A cross sectional observational study within the look AHEAD type 2 diabetes cohort.
    J Diabetes Complications. 2025;39:109161.
    PubMed     Abstract available
    
    
    
13. JAMES S, Barber R, Forster J, Sawatsky L, et al
    Atypical complications and co-morbidities of type 1 diabetes in young adults.
    J Diabetes Complications. 2025;39:109158.
    PubMed     Abstract available
    
    
    
14. HERMAN WH, Villatoro C, Joiner KL, McEwen LN, et al
    Corrigendum to "Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience" [J. Diabetes Complicat. (2023) 108527].
    J Diabetes Complications. 2025 Aug 26:109157.
    PubMed    
    
    
    
15. JI L, Abudulam R, Li M
    Letter to the Editor "The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review".
    J Diabetes Complications. 2025 Aug 25:109155.
    PubMed    
    
    
    
16. KIM J, Bae S, Yun D, Park S, et al
    Clinical outcomes of and risk factors for normoalbuminuric diabetic kidney disease.
    J Diabetes Complications. 2025;39:109154.
    PubMed     Abstract available
    
    
    
17. WANG X, Yang S
    Letter to "Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study".
    J Diabetes Complications. 2025 Aug 21:109156.
    PubMed    
    
    
    
18. SCHMITTLING KA
    Risk assessment modeling for diabetes-related lower extremity amputation using socioeconomic and behavioral health indicators.
    J Diabetes Complications. 2025;39:109153.
    PubMed     Abstract available
    
    
    
19. HJORTKJAER HO, Rossing P, Kofoed KF
    Burden and progression of arterial calcification in type 1 diabetes predicts future cardiovascular disease.
    J Diabetes Complications. 2025;39:109152.
    PubMed     Abstract available
    
    
    
20. TIAN J, Zhao C, Li Y, Han Y, et al
    The impact of glycemic variability on the 28-day prognosis of patients with cardiogenic shock with or without diabetes mellitus: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109151.
    PubMed     Abstract available
    
    
    
21. WATANABE K, Nishioka H, Takubo M, Kosuda M, et al
    Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109150.
    PubMed     Abstract available
    
    
    
22. CHEN KY, Chan HC, Chan CM
    Is there a link between dry eye disease and diabetes mellitus? A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109149.
    PubMed     Abstract available
    
    
    
23. MUZUROVIC E, Topic G, Todorovic N, Rizzo M, et al
    The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.
    J Diabetes Complications. 2025;39:109147.
    PubMed     Abstract available
    
    
    July 2025
24. NISHIZAWA K, Tanaka M, Sato T, Gohda T, et al
    The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapy.
    J Diabetes Complications. 2025;39:109146.
    PubMed     Abstract available
    
    
    
25. BOMBACI B, Passanisi S, Longo A, Aramnejad S, et al
    The interplay between psychological well-being, diabetes-related distress, and glycemic control: A continuous glucose monitoring analysis from a population of adolescents with type 1 diabetes.
    J Diabetes Complications. 2025;39:109142.
    PubMed     Abstract available
    
    
    
26. BAIER JM, Funck KL, Vernstrom L, Gullaksen S, et al
    Effect of colchicine on platelet aggregation in patients with type 2 diabetes: Results from a randomized placebo-controlled trial.
    J Diabetes Complications. 2025;39:109141.
    PubMed     Abstract available
    
    
    
27. SACCHINI F, Mancin S, Cangelosi G, Palomares SM, et al
    The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review.
    J Diabetes Complications. 2025;39:109139.
    PubMed     Abstract available
    
    
    
28. YANG Z, Zheng B, Luo G, Xin X, et al
    Associations of time in range and glycemic risk index with insulin resistance and diabetic kidney disease in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109140.
    PubMed     Abstract available
    
    
    
29. YE J, Qin Y, Zhao L, Yang L, et al
    Relationship between relative fat mass and coronary artery calcification in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109133.
    PubMed     Abstract available
    
    
    
30. MARIA AURORA RW, Paolo P
    What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?
    J Diabetes Complications. 2025;39:109132.
    PubMed     Abstract available
    
    
    
31. VEZINA-IM LA, Turcotte AF, Messier V, Turcotte S, et al
    BETTER sleep: Sleep quality among adults living with type 1 diabetes in Canada.
    J Diabetes Complications. 2025;39:109137.
    PubMed     Abstract available
    
    
    
32. ZHENG D, Cui C
    Elevated small dense low-density lipoprotein-cholesterol as a risk factor for lower extremity arterial disease in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109136.
    PubMed     Abstract available
    
    
    
33. DISSANAYAKE HA, Kiire CA, Preiss D, Tan GD, et al
    The use of fenofibrate in diabetic retinopathy: Narrative review.
    J Diabetes Complications. 2025;39:109135.
    PubMed     Abstract available
    
    
    
34. DE OLIVEIRA HM, Gallo Ruelas M, Flavio-Reis VHP, Queiroz I, et al
    Degludec insulin versus efsitora insulin in diabetes mellitus management: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109115.
    PubMed     Abstract available
    
    
    
35. HUBER SL, Parzer V, Ludvik B, Pollreisz A, et al
    Evaluation of IDx-DR software for diabetic retinopathy screening in outpatient clinics: Efficacy, safety, and feasibility in a real-world setting.
    J Diabetes Complications. 2025;39:109120.
    PubMed     Abstract available
    
    
    
36. ZHANG Z, Yang R, Wu W, Wang Z, et al
    Association of aortic pulse wave velocity with cardiovascular outcomes and all-cause mortality in diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109118.
    PubMed     Abstract available
    
    
    
37. LIU Y, Yue J, Jiang Y, Tian X, et al
    The role of circRNA in insulin resistance and its progression induced by adipose inflammation.
    J Diabetes Complications. 2025;39:109042.
    PubMed     Abstract available
    
    
    June 2025
38. COWART K, Murphy C, Carris N
    Association of tirzepatide with erectile dysfunction in people with type 2 diabetes.
    J Diabetes Complications. 2025;39:109116.
    PubMed     Abstract available
    
    
    
39. DAVILA-GARCIA DM, Falconer T, Pratt N, Natarajan K, et al
    Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence.
    J Diabetes Complications. 2025;39:109114.
    PubMed     Abstract available
    
    
    
40. OZGUMUS T, Sulaieva O, Begum MC, Ekstrom O, et al
    DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications.
    J Diabetes Complications. 2025;39:109112.
    PubMed     Abstract available
    
    
    
41. CARRIS NW, Mhaskar R, Coughlin E, Bracey E, et al
    A mediation analysis assessing if interleukin-6 mediates the association between obesity and new-onset type-2-diabetes.
    J Diabetes Complications. 2025;39:109110.
    PubMed     Abstract available
    
    
    
42. PALBRINK AK, Magnusson M, Degerman E
    Modulation of the sodium-chloride cotransporter by insulin in auditory cells: A potential link to diabetes-related hearing complications.
    J Diabetes Complications. 2025;39:109111.
    PubMed     Abstract available
    
    
    
43. SANTOS VKJD, Prado MLL, Da Silva GSN, Sant'anna Aragao IC, et al
    Technosphere insulin in the treatment of Type 1 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109108.
    PubMed     Abstract available
    
    
    
44. TAL N, Hershkowitz I, Gorin K, Leibovitch M, et al
    Clinical outcomes of patients with Polyvascular disease admitted with an acute diabetic foot ulcer.
    J Diabetes Complications. 2025;39:109109.
    PubMed     Abstract available
    
    
    
45. GALIERO R, Rezki A, Simeon V, Beccia D, et al
    NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy.
    J Diabetes Complications. 2025;39:109107.
    PubMed     Abstract available
    
    
    
46. SULTAN S, Sabeeh R
    Impact of gestational and type 2 diabetes on fetal endothelial cell miRNA expression.
    J Diabetes Complications. 2025;39:109106.
    PubMed     Abstract available
    
    
    
47. QUADRA MR, Schafer AA, Meller FO, Martins CD, et al
    Relationship between body fat and cognitive function in individuals with diabetes mellitus.
    J Diabetes Complications. 2025;39:109105.
    PubMed     Abstract available
    
    
    May 2025
48. FAN J, Zuo L, Liu X, Tang Y, et al
    Incremental value of CT-based perirenal fat characteristics in the categorization and progression prediction of diabetic kidney disease.
    J Diabetes Complications. 2025;39:109104.
    PubMed     Abstract available
    
    
    
49. JLALI I, Touil I, Amor HH, Tagougui S, et al
    Impaired cerebral hemodynamics and oxygenation in type 2 diabetes: insights into insulin resistance and hyperglycemia effects.
    J Diabetes Complications. 2025;39:109102.
    PubMed     Abstract available
    
    
    
50. YILDIRIM AT, Bayar NTI, Yigit Y, Ersoy B, et al
    The role of biomarkers of innate and adaptive immunity in the early detection of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus.
    J Diabetes Complications. 2025;39:109090.
    PubMed     Abstract available
    
    
    
51. EIN-GAL Y, Aharon-Hananel G, Sigawi T, Hamtzany O, et al
    A national quality survey of in-patient diabetic foot care calls for centralizing care and improving patient communication.
    J Diabetes Complications. 2025;39:109088.
    PubMed     Abstract available
    
    
    
52. SOTO-HERNAEZ J, McCrimmon RJ, Pearson ER, Soto-Pedre E, et al
    Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study.
    J Diabetes Complications. 2025;39:109089.
    PubMed     Abstract available
    
    
    
53. SEBASTIAN-VALLES F, Santiago-Redondo A, Garcia-Artacho E, Sampedro-Nunez MA, et al
    Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study.
    J Diabetes Complications. 2025;39:109082.
    PubMed     Abstract available
    
    
    
54. UBERALL MA, Kender Z, Quandel T, Engelen S, et al
    Progressive improvements in patient-reported outcomes with the high-concentration capsaicin patch: A retrospective cohort study in patients with painful diabetic peripheral neuropathy (CASPAR study).
    J Diabetes Complications. 2025;39:109085.
    PubMed     Abstract available
    
    
    
55. PAPANAS N, Tsimihodimos V, Katsiki N, Doupis J, et al
    Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study).
    J Diabetes Complications. 2025;39:109087.
    PubMed     Abstract available
    
    
    
56. SCHMIDT CB, Keijsper E, Bosmans JE, van Loon BJP, et al
    Medical costs and health care utilization in Dutch diabetes patients with high levels of diabetes-distress.
    J Diabetes Complications. 2025;39:109086.
    PubMed     Abstract available
    
    
    
57. TILLQVIST H, Vuorlaakso M, Helminen M, Kiiski J, et al
    Clinical frailty scale as a tool to predict outcomes after lower extremity amputation among patients with diabetes: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109084.
    PubMed     Abstract available
    
    
    
58. PLAITANO EG, Stanger C
    Joint effect of nicotine use and diabetes distress on glycemic control in young adults with type 1 diabetes.
    J Diabetes Complications. 2025;39:109083.
    PubMed     Abstract available
    
    
    
59. PRIESTERROTH LS, Grammes J, Kubiak T
    Subtypes of disordered eating and their diabetes-related and psychosocial concomitants in adults with type 1 diabetes.
    J Diabetes Complications. 2025;39:109067.
    PubMed     Abstract available
    
    
    
60. IWAMOTO T, Morita M, Hidaka S, Sada K, et al
    Differential impact of short-term and long-term glycemic variability on peripheral nerve function in type 2 diabetes: A 5-year cohort study.
    J Diabetes Complications. 2025;39:109081.
    PubMed     Abstract available
    
    
    
61. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration.
    J Diabetes Complications. 2025;39:109069.
    PubMed     Abstract available
    
    
    
62. MAJD Z, Chen H, Johnson ML, Birtcher KK, et al
    Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug naive type 2 diabetes patients.
    J Diabetes Complications. 2025;39:109080.
    PubMed     Abstract available
    
    
    
63. NORLEN T, Olesen TB, Domazet SL, Nielsen JS, et al
    Physical activity and albuminuria in individuals recently diagnosed with type 2 diabetes.
    J Diabetes Complications. 2025;39:109065.
    PubMed     Abstract available
    
    
    
64. MIYOSHI K, Aoyama T, Kameda S, Ishibashi N, et al
    Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109068.
    PubMed     Abstract available
    
    
    
65. PERTILE P, D'Ippolito I, De Santis B, Andreadi A, et al
    External validation of a clinical risk score for the presence of cardiovascular autonomic neuropathy in type 1 diabetes.
    J Diabetes Complications. 2025;39:109066.
    PubMed     Abstract available
    
    
    
66. LI Q, Zhang M, Gao Q, Chen X, et al
    High fat-induced the upregulation of LOX-1 in RF/6A cells under high glucose condition.
    J Diabetes Complications. 2025;39:109019.
    PubMed     Abstract available
    
    
    April 2025
67. AL HAYEK A, Klonoff DC, Al Zahrani WM, Ibrahim SE, et al
    Evaluating the effect of Semaglutide as add-on therapy on glycemic control and continuous glucose monitoring outcomes in adults with type 1 diabetes: A two-year real-world data study.
    J Diabetes Complications. 2025;39:109064.
    PubMed     Abstract available
    
    
    
68. KIYAK-KIRMACI H, Hazar-Yavuz AN, Polat EB, Alsaadoni H, et al
    Effects of empagliflozin and dapagliflozin, SGLT2 inhibitors, on miRNA expressions in diabetes-related cardiovascular damage in rats.
    J Diabetes Complications. 2025;39:109063.
    PubMed     Abstract available
    
    
    
69. SHINOUCHI R, Shibata K, Nagatsuka T, Hasumi K, et al
    Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model.
    J Diabetes Complications. 2025;39:109061.
    PubMed     Abstract available
    
    
    
70. BARBARESKO J, Lang A, Schiemann TB, Schaefer E, et al
    Dietary factors and cancer outcomes in individuals with type 2 diabetes: A systematic review and meta-analysis of prospective observational studies.
    J Diabetes Complications. 2025;39:109060.
    PubMed     Abstract available
    
    
    
71. SIDDIQI TJ, Liu Y, Zannad F, Tang WHW, et al
    Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF.
    J Diabetes Complications. 2025;39:109059.
    PubMed     Abstract available
    
    
    
72. COLACCI M, Raudanskis A, Fralick M
    Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes.
    J Diabetes Complications. 2025 Apr 23:109046.
    PubMed    
    
    
    
73. PENNISI G, Petta S, Maggio V, Rizzo M, et al
    GLP-1 receptor agonists and MASLD in diabetes: A promising path?
    J Diabetes Complications. 2025 Apr 22:109041.
    PubMed    
    
    
    
74. SOLTANI P, Almeida FM, Melo HCC, Ferreira GBS, et al
    Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study.
    J Diabetes Complications. 2025;39:109043.
    PubMed     Abstract available
    
    
    
75. VOZIKI D, Dimakopoulos G, Stergiou I, Zografou I, et al
    The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109044.
    PubMed     Abstract available
    
    
    
76. GULLAKSEN S, Vernstrom L, Sorensen SS, Funck KL, et al
    Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial.
    J Diabetes Complications. 2025;39:109039.
    PubMed     Abstract available
    
    
    
77. WEINGARTEN SJ, Levy AT, Al-Kouatly HB, McLaren RA Jr, et al
    Postpartum diabetes mellitus among patients with early gestational diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109038.
    PubMed     Abstract available
    
    
    
78. ZHANG X, Wang Y, Zhao H, Chen S, et al
    A retrospective study to investigate the risk factors for gestational diabetes mellitus and its impact on maternal and neonatal outcomes.
    J Diabetes Complications. 2025;39:109035.
    PubMed     Abstract available
    
    
    
79. SHORA HA, El-Deen IM, El-Lithy NM, Abo-Elmatty DM, et al
    Growth differentiation factor-15: A marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease.
    J Diabetes Complications. 2025;39:109037.
    PubMed     Abstract available
    
    
    
80. ASENSIO-SANCHEZ VM
    Comments on the article "the association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier ".
    J Diabetes Complications. 2025;39:108948.
    PubMed    
    
    
    
81. PAK LK, Le MV, Kevat D, Barmanray R, et al
    Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 agonist use in hospital among adults with diabetes.
    J Diabetes Complications. 2025 Apr 3:109022. doi: 10.1016/j.jdiacomp.2025.109022
    PubMed    
    
    
    
82. KING J, Buschur E, Garcetti R, Pyle L, et al
    Changes to insulin pump settings throughout pregnancy for individuals using assisted hybrid closed-loop therapy versus sensor-augmented pump therapy.
    J Diabetes Complications. 2025;39:109000.
    PubMed     Abstract available
    
    
    
83. PAPA G, Cannarella R, Finocchiaro C, Anzaldi M, et al
    Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaire.
    J Diabetes Complications. 2025;39:108984.
    PubMed     Abstract available
    
    
    March 2025
84. ZHANG W, Sun C, Huang Y, Zhang M, et al
    Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy.
    J Diabetes Complications. 2025;39:109017.
    PubMed     Abstract available
    
    
    
85. OZEL HF, Alpay S, Asker E, Gultekin ES, et al
    SGLT-2 inhibitors on cardiac autonomic function in individuals with and without type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109021.
    PubMed     Abstract available
    
    
    
86. ANASTASIOU G, Maggio V, Rizzo M, Liberopoulos E, et al
    Lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy.
    J Diabetes Complications. 2025 Mar 26:109020.
    PubMed    
    
    
    
87. VAS PRJ, Maggio V, Rizzo M, Papanas N, et al
    Diabetic neuropathy in adolescents and young adults: The need for early detection and improved understanding.
    J Diabetes Complications. 2025 Mar 24:109018.
    PubMed    
    
    
    
88. KERR M, Wild D, Edmonds M, Boulton AJM, et al
    Cost effectiveness of topical wound oxygen therapy for chronic diabetic foot ulcers.
    J Diabetes Complications. 2025;39:109016.
    PubMed     Abstract available
    
    
    
89. FOJAS EG, Haidery A, Naseeb S, Naemi R, et al
    Type 2 diabetes and cardiovascular conditions prediction in individuals with metabolic syndrome-associated lipoprotein lipase gene (LPL) single nucleotide polymorphisms (SNPs).
    J Diabetes Complications. 2025;39:109003.
    PubMed     Abstract available
    
    
    
90. DEL ZOPPO A, Rovera C, Petralli G, Moriconi D, et al
    Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation.
    J Diabetes Complications. 2025;39:109015.
    PubMed     Abstract available
    
    
    
91. GKIOURTZIS N, Stoimeni A, Michou P, Cheirakis K, et al
    The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109002.
    PubMed     Abstract available
    
    
    
92. WULANDARI N, Lamuri A, van Hasselt F, Feenstra T, et al
    The burden of depression among patients with type 2 diabetes: An umbrella review of systematic reviews.
    J Diabetes Complications. 2025;39:109004.
    PubMed     Abstract available
    
    
    
93. AHN J, Shahriarirad R, Kwon K, Bejarano-Pineda L, et al
    Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study.
    J Diabetes Complications. 2025;39:109001.
    PubMed     Abstract available
    
    
    
94. OLIVEIRA SB, Silveira ALPA, Kim YJ, do Amaral JB, et al
    Effect of non-surgical treatment in diabetes-associated periodontitis on immune/inflammatory and oxidative stress biomarkers: A pilot study.
    J Diabetes Complications. 2025;39:108999.
    PubMed     Abstract available
    
    
    
95. SEO JE, Rizzo M, Powell-Wiley TM
    Integrating social determinants of health into global approaches to early-onset type 2 diabetes.
    J Diabetes Complications. 2025;39:108982.
    PubMed    
    
    
    
96. JIN M, Bao Z, Hong X, He S, et al
    The prognostic value of the stress hyperglycemia ratio for all-cause mortality in stroke patients with diabetes or prediabetes.
    J Diabetes Complications. 2025;39:108979.
    PubMed     Abstract available
    
    
    
97. LIU L, Deng Y, Yang L, Wang M, et al
    Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis.
    J Diabetes Complications. 2025;39:108998.
    PubMed     Abstract available
    
    
    
98. ROLLINS J, Hong AL, Schroader B, Kong SX, et al
    Guideline-directed medical therapies (GDMTs) for chronic kidney disease with type 2 diabetes (CKD + T2D): Translation of lessons learned from the management of heart failure.
    J Diabetes Complications. 2025;39:108985.
    PubMed     Abstract available
    
    
    
99. ZARAGOZA-GARCIA O, Briceno O, Villafan-Bernal JR, Rojas-Delgado HU, et al
    sCD14 as a biomarker for the progression of kidney disease among patients with diabetes.
    J Diabetes Complications. 2025;39:108980.
    PubMed     Abstract available
    
    
    February 2025
100. HA KH, Kim W, Kim DH, Kim DJ, et al
     Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study.
     J Diabetes Complications. 2025;39:108983.
     PubMed     Abstract available
     
     
     
101. LIU R, Qu Z, Feng Y, Bai L, et al
     Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i.
     J Diabetes Complications. 2025;39:108981.
     PubMed     Abstract available
     
     
     
102. VAN BEURDEN W, Mendoza YP, Lange NF, Bosch J, et al
     FIB-4 predicts events in compensated advanced chronic liver disease and type 2 diabetes treated with GLP-1-receptor-agonists.
     J Diabetes Complications. 2025;39:108978.
     PubMed     Abstract available
     
     
     
103. LEE JC, Chong JW, Kumar S
     Highlighting the complex relationship between diabetes, renal function and bone health.
     J Diabetes Complications. 2025;39:108974.
     PubMed    
     
     
     
104. XU Q, Qiu X, Di H, Li Z, et al
     Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway.
     J Diabetes Complications. 2025;39:108975.
     PubMed     Abstract available
     
     
     
105. PATANI K, Joharapurkar A, Sundar R, Kshirsagar S, et al
     Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models.
     J Diabetes Complications. 2025;39:108977.
     PubMed     Abstract available
     
     
     
106. ZHANG XY, Xu YX, Xue SQ, Zeng YQ, et al
     Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-beta1/Smad signaling pathway.
     J Diabetes Complications. 2025;39:108976.
     PubMed     Abstract available
     
     
     
107. MACKAY K, Thompson R, Parker M, Pedersen J, et al
     The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers - A literature review.
     J Diabetes Complications. 2025;39:108973.
     PubMed     Abstract available
     
     
     
108. HOUGHTON JM, Hynes MC, Roberts NW, van der Westhuizen HM, et al
     Implementation of evidence-based foot screening in people with diabetes: A scoping review.
     J Diabetes Complications. 2025;39:108972.
     PubMed     Abstract available
     
     
     
109. ROSIEN L, Bilo HJG, Oskam J, Ruwaard D, et al
     Long-term mortality rates after lower extremity amputation in individuals with and without diabetes mellitus (DUDE-10): A retrospective matched cohort study.
     J Diabetes Complications. 2025;39:108956.
     PubMed     Abstract available
     
     
     
110. HIRANO Y, Tsuriya D, Kono K, Fujikura T, et al
     Association between muscle fatigability and diabetic kidney disease complications in patients with type 2 diabetes.
     J Diabetes Complications. 2025;39:108955.
     PubMed     Abstract available
     
     
     
111. DING T, Song M, Wang S, Huang C, et al
     Dapagliflozin has protective effects on palmitate-induced renal tubular epithelial cells by enhancing mitochondrial function and reducing oxidative stress.
     J Diabetes Complications. 2025;39:108930.
     PubMed     Abstract available
     
     
     January 2025
112. GAO H, Chen S, Li J, Liu Y, et al
     Elaboration and verification of immune-based diagnostic biomarker panel for diabetic foot ulcer.
     J Diabetes Complications. 2025;39:108957.
     PubMed     Abstract available
     
     
     
113. OKORO FO, Markus V
     Artificial sweeteners and Type 2 Diabetes Mellitus: A review of current developments and future research directions.
     J Diabetes Complications. 2025;39:108954.
     PubMed     Abstract available
     
     
     
114. MOH MC, Low S, Pek SLT, Liu JJ, et al
     Association of dysfunctional adiposity index with kidney impairment is accounted for by pigment epithelium-derived factor in type 2 diabetes mellitus - An 11-year follow-up of the SMART2D cohort study.
     J Diabetes Complications. 2025;39:108953.
     PubMed     Abstract available
     
     
     
115. YANG Y, Li F, Li Y, Li X, et al
     Nicotinamide n-methyltransferase inhibitor synergizes with sodium-glucose cotransporter 2 inhibitor to protect renal tubular epithelium in experimental models of type 2 diabetes mellitus.
     J Diabetes Complications. 2025;39:108952.
     PubMed     Abstract available
     
     
     
116. HE Y, Ye M, Shen Z, Zhong Z, et al
     Correlation between lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: A cross-sectional study.
     J Diabetes Complications. 2025;39:108950.
     PubMed     Abstract available
     
     
     
117. SCHMITTLING KA
     Behavioral health comorbidities in hospital outcomes post-lower extremity amputation in patients with type 1 and type 2 diabetes.
     J Diabetes Complications. 2025;39:108949.
     PubMed     Abstract available
     
     
     
118. YARIBEYGI H, Kashian K, Moghaddam KI, Karim SR, et al
     Hepatic effects of GLP-1 mimetics in diabetic milieu: A mechanistic review of involved pathways.
     J Diabetes Complications. 2025;39:108928.
     PubMed     Abstract available
     
     
     
119. SIDRA FNU, Agarwal S, Lockhart Pastor P, Xie D, et al
     Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy.
     J Diabetes Complications. 2025;39:108925.
     PubMed     Abstract available
     
     
     
120. LEE H, Hartfield PJ, Thorgerson A, Sinson GP, et al
     Cambridge risk score, new hyperglycemia, and complications in surgical patients without diabetes.
     J Diabetes Complications. 2025;39:108926.
     PubMed     Abstract available
     
     
     December 2024
121. LIU S, Ke J, Feng X, Xu Y, et al
     Diabetic microvascular complications are associated with left ventricular hypertrophy in patients with type 2 diabetes mellitus.
     J Diabetes Complications. 2024;39:108947.
     PubMed     Abstract available
     
     
     
122. BARMPAGIANNI A, Karamanakos G, Anastasiou IA, Kountouri A, et al
     The relationship between residual insulin secretion and subclinical cardiovascular risk indices in young adults with type 1 diabetes.
     J Diabetes Complications. 2024;39:108946.
     PubMed     Abstract available
     
     
     
123. RAUDANSKIS A, Sarma S, Biering-Sorensen T, Zorcic K, et al
     Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes.
     J Diabetes Complications. 2024;39:108945.
     PubMed     Abstract available
     
     
     
124. ADDINGTON KS, Kristiansen M, Hempler NF, Frimodt-Moller M, et al
     Incidence of early-onset type 2 diabetes and sociodemographic predictors of complications: A nationwide registry study.
     J Diabetes Complications. 2024;39:108942.
     PubMed     Abstract available
     
     
     
125. OSMAN AAM, Seres-Bokor A, Ducza E
     Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications.
     J Diabetes Complications. 2024;39:108941.
     PubMed     Abstract available
     
     
     
126. REN R, Pei Y, Kong L, Shi Y, et al
     The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease.
     J Diabetes Complications. 2024;39:108932.
     PubMed     Abstract available
     
     
     
127. HAUGE SC, Hjortkjaer HO, Persson F, Theilade S, et al
     Bone mineral density and the risk of kidney disease in patients with type 1 diabetes.
     J Diabetes Complications. 2024;39:108927.
     PubMed     Abstract available
     
     
     
128. LI X, Huang B, Liu Y, Wang M, et al
     Uric acid in diabetic microvascular complications: Mechanisms and therapy.
     J Diabetes Complications. 2024;39:108929.
     PubMed     Abstract available
     
     
     
129. GEORGE BL, Perez AM, Rodriguez P, Parekh P, et al
     The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier.
     J Diabetes Complications. 2024;39:108931.
     PubMed     Abstract available
     
     
     
130. HEINRICH NS, Pedersen RP, Vestergaard MB, Lindberg U, et al
     Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease.
     J Diabetes Complications. 2024;39:108923.
     PubMed     Abstract available
     
     
     
131. YARIBEYGI H, Maleki M, Forouzanmehr B, Kesharwani P, et al
     Exploring the antioxidant properties of semaglutide: A comprehensive review.
     J Diabetes Complications. 2024;38:108906.
     PubMed     Abstract available
     
     
     
132. GONZALEZ-VIDAL T, Rivas-Otero D, Ares-Blanco J, Lambert C, et al
     Real-life evaluation of consensus recommendations for transition to subcutaneous insulin in hyperosmolar hyperglycemic crises.
     J Diabetes Complications. 2024;38:108902.
     PubMed     Abstract available
     
     
     
133. HONG SH, Jee Y, Sung YA, Hong YS, et al
     Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales.
     J Diabetes Complications. 2024;39:108924.
     PubMed     Abstract available
     
     
     November 2024
134. ZHENG Z, Cao B, Ke J, Zhao D, et al
     The effect of long-term glycemic burden on the incidence of diabetic foot ulcers: A retrospective study.
     J Diabetes Complications. 2024;39:108901.
     PubMed     Abstract available
     
     
     
135. YOKOMICHI H, Mochizuki M, Suzuki S, Ito Y, et al
     Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan.
     J Diabetes Complications. 2024;39:108922.
     PubMed     Abstract available
     
     
     
136. CARDOSO CRL, da Silva Pereira L, Leite NC, Salles GF, et al
     Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort.
     J Diabetes Complications. 2024;39:108921.
     PubMed     Abstract available
     
     
     
137. ALFADDA AA, Alqutub AN, Sherbeeni SM, Aldosary AS, et al
     Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD.
     J Diabetes Complications. 2024;39:108910.
     PubMed     Abstract available
     
     
     
138. VARUGHESE MS, Nayak AU
     Diabetic macular edema: Variations in observations with intensive treatment optimizing glycemia.
     J Diabetes Complications. 2024;39:108909.
     PubMed    
     
     
     
139. WADA S, Iwanaga Y, Nakai M, Noguchi T, et al
     Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment.
     J Diabetes Complications. 2024;39:108908.
     PubMed     Abstract available
     
     
     
140. PANTAZOPOULOS D, Gouveri E, Rizzo M, Papanas N, et al
     Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?
     J Diabetes Complications. 2024;38:108905.
     PubMed     Abstract available
     
     
     
141. ROONEY MR, Norby FL, Soliman EZ, Chen LY, et al
     Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study.
     J Diabetes Complications. 2024;38:108903.
     PubMed     Abstract available
     
     
     
142. LAWRENCE CM, Smart CE, Fatima A, King BR, et al
     Increased bolus overrides and lower time in range: Insights into disordered eating revealed by insulin pump metrics and continuous glucose monitor data in Australian adolescents with type 1 diabetes.
     J Diabetes Complications. 2024;38:108904.
     PubMed     Abstract available
     
     
     
143. DIMOVA R, Chakarova N, Serdarova M, Tankova T, et al
     Lipid profile is similar in both subjects with high 1-hour postload glucose and 2-hour postload glucose and is related to cardio-metabolic profile in prediabetes.
     J Diabetes Complications. 2024;38:108869.
     PubMed     Abstract available
     
     
     
144. BAKER CJ, Min D, Marsh-Wakefield F, Siwan E, et al
     Circulating CD31(+) Angiogenic T cells are reduced in prediabetes and increase with exercise training.
     J Diabetes Complications. 2024;38:108868.
     PubMed     Abstract available
     
     
     October 2024
145. GOLBETS E, Sagy I, Ribak Z, Ben David R, et al
     Clinical features and outcomes of patients diagnosed with diabetic ketoacidosis (DKA) who were hospitalized for conditions outside of internal medicine.
     J Diabetes Complications. 2024;38:108900.
     PubMed     Abstract available
     
     
     
146. TSAI MH, Chien WC, Lin HC, Chung CH, et al
     Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin.
     J Diabetes Complications. 2024;38:108898.
     PubMed     Abstract available
     
     
     
147. HERDER C, Rizzo M, Roden M
     Precision diabetology: Where do we stand now?
     J Diabetes Complications. 2024 Oct 24:108899.
     PubMed    
     
     
     
148. STOUGAARD EB, Tougaard NH, Sivalingam S, Hansen CS, et al
     Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Study.
     J Diabetes Complications. 2024;38:108892.
     PubMed     Abstract available
     
     
     
149. HUANG C, Lin S, Yan Z, Yu W, et al
     Effects of moderate-intensity aerobic training on cardiac structure and function in type 2 mellitus diabetic rats: Based on echocardiography and speckle tracking.
     J Diabetes Complications. 2024;38:108896.
     PubMed     Abstract available
     
     
     
150. VARKEVISSER RDM, Sas T, Aanstoot HJ, Wolffenbuttel BHR, et al
     Residual C-peptide is associated with new and persistent impaired awareness of hypoglycaemia in type 1 diabetes.
     J Diabetes Complications. 2024;38:108893.
     PubMed     Abstract available
     
     
     
151. SHAKOUR N, Mahdinezhad MR, Asgharzadeh F, Khazaei M, et al
     Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture.
     J Diabetes Complications. 2024;38:108897.
     PubMed     Abstract available
     
     
     
152. TENTOLOURIS A, Stefanou MI, Vrettou AV, Palaiodimou L, et al
     Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: A systematic review.
     J Diabetes Complications. 2024;38:108883.
     PubMed     Abstract available
     
     
     
153. CHEONG SS, Samah N, Che Roos NA, Ugusman A, et al
     Prognostic value of pulse wave velocity for cardiovascular disease risk stratification in diabetic patients: A systematic review and meta-analysis.
     J Diabetes Complications. 2024;38:108894.
     PubMed     Abstract available
     
     
     
154. DEFANTE MLR, de Souza MM, Mendes BX, De Hollanda Morais BAA, et al
     Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials.
     J Diabetes Complications. 2024;38:108882.
     PubMed     Abstract available
     
     
     
155. PUTULA E, Kauppala T, Vanhamaki S, Haapakoski J, et al
     All-cause mortality and factors associated with it in finnish patients with type 1 diabetes.
     J Diabetes Complications. 2024;38:108881.
     PubMed     Abstract available
     
     
     
156. TU Q, Hyun K, Lin S, Hafiz N, et al
     Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study.
     J Diabetes Complications. 2024;38:108878.
     PubMed     Abstract available
     
     
     
157. HUANG JX, Casper TC, Pitts C, Myers SR, et al
     Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes.
     J Diabetes Complications. 2024;38:108880.
     PubMed     Abstract available
     
     
     
158. FERREIRA-DIVINO LF, Poulsen CG, Rotbain Curovic V, Pedersen OB, et al
     Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease.
     J Diabetes Complications. 2024;38:108879.
     PubMed     Abstract available
     
     
     
159. KOWALL B, Maier G, Rathmann W
     Too good to be true: Are GLP-1 receptor agonists the new metformin?
     J Diabetes Complications. 2024;38:108851.
     PubMed     Abstract available
     
     
     
160. CAO W, Zou J, Gao M, Huang J, et al
     A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-beta test.
     J Diabetes Complications. 2024;38:108831.
     PubMed     Abstract available
     
     
     
161. RIZOS EC, Ntzani EE, Rangraze IR, El-Tanani M, et al
     The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?
     J Diabetes Complications. 2024;38:108877.
     PubMed     Abstract available
     
     
     September 2024
162. NANDAKUMAR D, Johnson MJ, Lavery LA, Conover BM, et al
     Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus.
     J Diabetes Complications. 2024;38:108876.
     PubMed     Abstract available
     
     
     
163. ALAN MS, Tayebi A, Afshar EJ, Alan SS, et al
     Association of detectable C-peptide levels with glycemic control and chronic complications in individuals with type 1 diabetes mellitus: A systematic review and meta-analysis.
     J Diabetes Complications. 2024;39:108867.
     PubMed     Abstract available
     
     
     
164. ZUNICA-GARCIA S, Javier Blanquer-Gregori JF, Sanchez-Ortiga R, Chicharro-Luna E, et al
     Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study.
     J Diabetes Complications. 2024;38:108871.
     PubMed     Abstract available
     
     
     
165. STANISZEWSKA A, Jones A, Rudd S, de Vocht F, et al
     Effectiveness of screening for foot complications in people with diabetes - A systematic review.
     J Diabetes Complications. 2024;38:108865.
     PubMed     Abstract available
     
     
     
166. JIANG Y, Wang X, Zhao X, Sun Y, et al
     The correlation between patients with type 2 diabetes mellitus and chronic microvascular complications during the glucose peak time.
     J Diabetes Complications. 2024;38:108866.
     PubMed     Abstract available
     
     
     
167. TEASDALE S, Dong X, Griffin A, Clark PJ, et al
     Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetes.
     J Diabetes Complications. 2024;38:108870.
     PubMed     Abstract available
     
     
     
168. DAMM JA, Dalgas-Madsen A, Hansen CS, Pilgaard KA, et al
     Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities.
     J Diabetes Complications. 2024;38:108873.
     PubMed     Abstract available
     
     
     
169. CARDENAS-SALAS JJ, Sierra Poyatos RM, Luca BL, Sanchez Lechuga B, et al
     REAL life study of subcutaneous SEMaglutide in patients with type 2 diabetes in SPain: Ambispective, multicenter clinical study. Results in the GLP1-experienced cohort.
     J Diabetes Complications. 2024;38:108874.
     PubMed     Abstract available
     
     
     
170. FAVEL K, Bone JN, Elliott T, Panagiotopoulos C, et al
     Classification of longitudinal estimated glomerular filtration rate trajectories in Canadian adults with type 1 diabetes.
     J Diabetes Complications. 2024;38:108864.
     PubMed     Abstract available
     
     
     
171. DAVIS TME, Bruce DG, Schimke K, Chubb SAP, et al
     The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I.
     J Diabetes Complications. 2024;38:108854.
     PubMed     Abstract available
     
     
     
172. GOMEZ-GARCIA EF, Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L, et al
     Dietary counseling, meal patterns, and diet quality in patients with type 2 diabetes mellitus with/without chronic kidney disease.
     J Diabetes Complications. 2024;38:108853.
     PubMed     Abstract available
     
     
     
173. KOLASA M, Arponen O, Kaartinen I, Saarinen E, et al
     Correlation of cerebral small vessel disease burden with outcome after lower extremity amputation.
     J Diabetes Complications. 2024;38:108829.
     PubMed     Abstract available
     
     
     August 2024
174. VUJOSEVIC S, Limoli C, Piccoli G, Costanzo E, et al
     A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography.
     J Diabetes Complications. 2024;38:108852.
     PubMed     Abstract available
     
     
     
175. ROKICKA D, Hudzik B, Wrobel M, Stoltny T, et al
     Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes.
     J Diabetes Complications. 2024;38:108850.
     PubMed     Abstract available
     
     
     
176. GOLDNEY J, Barker MM, Thomas M, Slater T, et al
     Age at onset of type 2 diabetes and prevalence of vascular disease and heart failure: Systematic review and dose-response meta-analysis.
     J Diabetes Complications. 2024;38:108849.
     PubMed     Abstract available
     
     
     
177. GENG XF, Shang WY, Qi ZW, Zhang C, et al
     The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis.
     J Diabetes Complications. 2024;38:108848.
     PubMed     Abstract available
     
     
     
178. EVIN F, Kirkgoz T, Atik T, Ak G, et al
     "Predicting diabetic kidney disease in youth with type 1 diabetes: Insights from genetic risk assessment".
     J Diabetes Complications. 2024;38:108833.
     PubMed     Abstract available
     
     
     
179. YI X, Pan Y, Peng H, Ren M, et al
     The optimal dose of metformin to control conversion to diabetes in patients with prediabetes: A meta-analysis.
     J Diabetes Complications. 2024;38:108846.
     PubMed     Abstract available
     
     
     
180. MOHLER R, Lotharius K, Moothedan E, Goguen J, et al
     Factors contributing to diabetic ketoacidosis readmission in hospital settings in the United States: A scoping review.
     J Diabetes Complications. 2024;38:108835.
     PubMed     Abstract available
     
     
     
181. XIE D, Yang K, Xu Y, Li Y, et al
     N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
     J Diabetes Complications. 2024;38:108801.
     PubMed     Abstract available
     
     
     
182. BILAL A, Yi F, Gonzalez GR, Ali M, et al
     Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysis.
     J Diabetes Complications. 2024;38:108783.
     PubMed     Abstract available
     
     
     July 2024
183. SARMA S, Hodzic-Santor B, Raissi A, Colacci M, et al
     Association of sodium glucose co-transporter-2 inhibitors with risk of diabetic ketoacidosis among hospitalized patients: A multicentre cohort study.
     J Diabetes Complications. 2024;38:108827.
     PubMed     Abstract available
     
     
     
184. JANUSZEWSKI AS, Grzelka-Wozniak A, Flotynska J, Jenkins AJ, et al
     An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.
     J Diabetes Complications. 2024;38:108828.
     PubMed     Abstract available
     
     
     
185. THYKJAER AS, Rosengaard L, Andersen N, Andresen J, et al
     Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study.
     J Diabetes Complications. 2024;38:108830.
     PubMed     Abstract available
     
     
     
186. ANITA NZ, Herrmann N, Ryoo SW, Major-Orfao C, et al
     Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes.
     J Diabetes Complications. 2024;38:108826.
     PubMed     Abstract available
     
     
     
187. BENITES-MEZA JK, Malo-Castillo J, Herrera-Anazco P, Benites-Zapata VA, et al
     Atherogenic markers and 1-year amputation risk in adults with diabetic foot in a tertiary level hospital: A retrospective cohort study.
     J Diabetes Complications. 2024;38:108810.
     PubMed     Abstract available
     
     
     
188. GIANATTI E, Davis WA, Davis TME
     Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase II.
     J Diabetes Complications. 2024;38:108811.
     PubMed     Abstract available
     
     
     
189. PATOULIAS D, Karakasis P, El-Tanani M, Rizzo M, et al
     Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?
     J Diabetes Complications. 2024;38:108812.
     PubMed    
     
     
     
190. TASMAN J, Clegg DJ, Carver C, Adabala S, et al
     Assessing the influence of rural residence and economic distress on lower extremity risk stratification among diabetic foot ulcer patients utilizing the Wound, Ischemia, and Foot Infection (WIfI) classification system.
     J Diabetes Complications. 2024;38:108814.
     PubMed     Abstract available
     
     
     
191. VARGHESE NM, Varghese JS
     Sex differences in association of joint glycemic, blood pressure and lipid control and two-year risk of falls among older adults with diabetes.
     J Diabetes Complications. 2024;38:108815.
     PubMed     Abstract available
     
     
     
192. JOUNG KH, Kim TN, Ku EJ, Lee SS, et al
     A phase 4 randomized active-controlled clinical study to compare the efficacy and safety of sustained-release pregabalin with immediate-release pregabalin in type 2 diabetic patients with peripheral neuropathic pain.
     J Diabetes Complications. 2024;38:108809.
     PubMed     Abstract available
     
     
     
193. PHU A, Banghart M, Bahrainian M, Liu TYA, et al
     Dipeptidyl peptidase 4 inhibitors, sodium glucose cotransporter 2 inhibitors, and glucagon-like peptide 1 receptor agonists do not worsen diabetic macular edema.
     J Diabetes Complications. 2024;38:108808.
     PubMed     Abstract available
     
     
     
194. WANG Z, Crowe FL, Tahrani AA, Singh P, et al
     The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review.
     J Diabetes Complications. 2024;38:108813.
     PubMed     Abstract available
     
     
     
195. YAY F, Bayram E, Aggul H, Guclu CO, et al
     Can immature granulocytes and neutrophil-lymphocyte ratio be biomarkers to evaluate diabetic nephropathy?: A cross-sectional study.
     J Diabetes Complications. 2024;38:108807.
     PubMed     Abstract available
     
     
     
196. ZHANG X, Qiu W, Huang J, Pang X, et al
     Insulin combined with N-acetylcysteine attenuates type 1 diabetes-induced splenic inflammatory injury in canines by inhibiting the MAPKs-NF-kappaB signaling pathway and pyroptosis.
     J Diabetes Complications. 2024;38:108805.
     PubMed     Abstract available
     
     
     
197. LIAO M, Wang X
     Ameliorating effect of Chinese jujube polyphenol on blood glucose oxidative stress in type 2 diabetic rats.
     J Diabetes Complications. 2024;38:108804.
     PubMed     Abstract available
     
     
     
198. RIZOS EC, Tagkas CF, Asimakopoulos AI, Tsimihodimos V, et al
     The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials.
     J Diabetes Complications. 2024;38:108781.
     PubMed     Abstract available
     
     
     June 2024
199. OLSEN MT, Klarskov CK, Hansen KB, Pedersen-Bjergaard U, et al
     Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia.
     J Diabetes Complications. 2024;38:108803.
     PubMed     Abstract available
     
     
     
200. DE PAULA AVL, Dykstra GM, da Rocha RB, Magalhaes AT, et al
     The association of diabetic peripheral neuropathy with cardiac autonomic neuropathy in individuals with diabetes mellitus: A systematic review.
     J Diabetes Complications. 2024;38:108802.
     PubMed     Abstract available
     
     
     
201. LUO Y, Qin Y, Kong L, Long J, et al
     Clinical and pathological characteristics of gestational diabetes mellitus with different insulin resistance.
     J Diabetes Complications. 2024;38:108796.
     PubMed     Abstract available
     
     
     
202. HERMANYI Z, Menyhart A, Korei AE, Istenes I, et al
     A comprehensive analysis of diabetic patient data before and during the COVID-19 pandemic - Lessons from the MERY diabetes database (MDD).
     J Diabetes Complications. 2024;38:108799.
     PubMed     Abstract available
     
     
     
203. POPOVIC DS, Patoulias D, Koufakis T, Stavropoulos K, et al
     Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?
     J Diabetes Complications. 2024;38:108800.
     PubMed     Abstract available
     
     
     
204. GOTTLIEB D, Abushamat LA, Nadeau KJ, Regensteiner JG, et al
     Muscle mitochondrial function is impaired in adults with type 1 diabetes.
     J Diabetes Complications. 2024;38:108798.
     PubMed     Abstract available
     
     
     
205. MUNDA A, Kovacic C, Pongrac Barlovic D
     Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study.
     J Diabetes Complications. 2024;38:108795.
     PubMed     Abstract available
     
     
     
206. PORTERFIELD L, Yu X, Warren V, Bowen ME, et al
     A community health worker led diabetes self-management education program: Reducing patient and system burden.
     J Diabetes Complications. 2024;38:108794.
     PubMed     Abstract available
     
     
     
207. KOVOOR JG, Rayner CK, Wu T, Jalleh RJ, et al
     Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - Implications for the use of GLP-1 receptor agonists before procedures.
     J Diabetes Complications. 2024;38:108793.
     PubMed     Abstract available
     
     
     May 2024
208. GEORELI E, Stamati A, Dimitriadou M, Chainoglou A, et al
     Assessment of arterial stiffness in paediatric patients with type 1 diabetes mellitus.
     J Diabetes Complications. 2024;38:108782.
     PubMed     Abstract available
     
     
     
209. SUZUKI T, Sato T, Tanaka M, Endo K, et al
     Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus.
     J Diabetes Complications. 2024;38:108779.
     PubMed     Abstract available
     
     
     
210. HALL RM, Marshall HJ, Parry-Strong A, Corley B, et al
     A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet.
     J Diabetes Complications. 2024;38:108778.
     PubMed     Abstract available
     
     
     
211. GATEVA A, Assyov Y, Karamfilova V, Kamenov Z, et al
     Common carotid artery intima media thickness (CIMT) in patients with prediabetes and newly diagnosed type 2 diabetes mellitus.
     J Diabetes Complications. 2024;38:108766.
     PubMed     Abstract available
     
     
     
212. SKRIVER-MOLLER AC, Moller AL, Blond MB, Rasmussen DGK, et al
     Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria.
     J Diabetes Complications. 2024;38:108765.
     PubMed     Abstract available
     
     
     
213. BOOKER R, Wong M, Bancks MP, Carnethon MR, et al
     The longitudinal association of adipose-to-lean ratio with incident cardiometabolic morbidity: The CARDIA study.
     J Diabetes Complications. 2024;38:108725.
     PubMed     Abstract available
     
     
     
214. SHAPIRO ALB, Tjaden AH, Edelstein SL, Kahn SE, et al
     The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study.
     J Diabetes Complications. 2024;38:108764.
     PubMed     Abstract available
     
     
     April 2024
215. YAMADA E, Kajita R, Takahashi H, Horiguchi K, et al
     Exploring potential correlations between HLA class II and the risk of microvascular complications in Japanese patients with type 1 diabetes.
     J Diabetes Complications. 2024;38:108763.
     PubMed     Abstract available
     
     
     
216. HUANG JX, Copeland TP, Pitts CE, Myers SR, et al
     Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes.
     J Diabetes Complications. 2024;38:108762.
     PubMed     Abstract available
     
     
     
217. MIZRAK HI, Kufaishi H, Hecquet SK, Hansen TW, et al
     Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic.
     J Diabetes Complications. 2024;38:108761.
     PubMed     Abstract available
     
     
     
218. PETTY LD, Soto-Pedre E, McCrimmon RJ, Pearson ER, et al
     Body Mass Index's influence on arterial hypertension in Type 1 diabetes - A brief report from IMI-SOPHIA study.
     J Diabetes Complications. 2024;38:108747.
     PubMed     Abstract available
     
     
     
219. NOMURA K, Inagaki S, Muramae N, Takahashi H, et al
     Association of short-term changes in HbA1c with body composition and the importance of muscle maintenance in patients with Type 2 diabetes.
     J Diabetes Complications. 2024;38:108746.
     PubMed     Abstract available
     
     
     
220. KUFAISHI H, Mizrak HI, Brock B, Hansen TW, et al
     Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort study.
     J Diabetes Complications. 2024;38:108745.
     PubMed     Abstract available
     
     
     
221. ZHAO D, Ma J, Sun Y, Huang W, et al
     Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
     J Diabetes Complications. 2024;38:108744.
     PubMed     Abstract available
     
     
     
222. XIE W, Hong Z, Li B, Huang B, et al
     Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials.
     J Diabetes Complications. 2024;38:108743.
     PubMed     Abstract available
     
     
     
223. GRACIA-RAMOS AE, Cruz-Dominguez MDP, Madrigal-Santillan EO, Rojas-Martinez R, et al
     Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
     J Diabetes Complications. 2024;38:108742.
     PubMed     Abstract available
     
     
     
224. FILARDI T, Feraco A, Ouvrard-Pascaud A, Rizzo M, et al
     Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.
     J Diabetes Complications. 2024;38:108741.
     PubMed    
     
     
     
225. LASSCHUIT JWJ, Center JR, Greenfield JR, Tonks KTT, et al
     Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial.
     J Diabetes Complications. 2024;38:108718.
     PubMed     Abstract available
     
     
     
226. RAKOTOARISOA L, Weiss L, Lefebvre F, Porzio M, et al
     Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
     J Diabetes Complications. 2024;38:108703.
     PubMed     Abstract available
     
     
     March 2024
227. FARAH R, Alhajahjeh A, Al-Farahid O, Abuzaid H, et al
     Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification.
     J Diabetes Complications. 2024;38:108740.
     PubMed     Abstract available
     
     
     
228. SUN Q, Yang P, Gu QW, Gu WS, et al
     Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients.
     J Diabetes Complications. 2024;38:108738.
     PubMed     Abstract available
     
     
     
229. LIU F, You F, Yang L, Wang S, et al
     Metformin improves diabetic neuropathy by reducing inflammation through up-regulating the expression of miR-146a and suppressing oxidative stress.
     J Diabetes Complications. 2024;38:108737.
     PubMed     Abstract available
     
     
     
230. FONSECA LM, Kanapka L, Miller K, Pratley R, et al
     Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study.
     J Diabetes Complications. 2024;38:108739.
     PubMed     Abstract available
     
     
     
231. SANTOS EAM, Zaccara TA, Paganoti CF, Peres SV, et al
     Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes.
     J Diabetes Complications. 2024;38:108724.
     PubMed     Abstract available
     
     
     
232. PINES-CORRALES PJ, Lopez-Garcia MC, Sanz-Velasco A, Moya-Moya AJ, et al
     Changes in glucometric parameters in people living with diabetes users of the free-style libre 2 system before and after the update possibility to real-time glucose readings in real world practice.
     J Diabetes Complications. 2024;38:108723.
     PubMed     Abstract available
     
     
     
233. CAMPOS AC, Lima EG, Jacobsen PK, Arnould L, et al
     Association between obstructive coronary disease and diabetic retinopathy: Cross-sectional study of coronary angiotomography and multimodal retinal imaging.
     J Diabetes Complications. 2024;38:108721.
     PubMed     Abstract available
     
     
     
234. TSUR N, Frankel M, Cahn A, Tsur A, et al
     Gestational diabetes and risk of future diabetes in a multi-ethnic population.
     J Diabetes Complications. 2024;38:108720.
     PubMed     Abstract available
     
     
     
235. VUORLAAKSO M, Karen V, Kiiski J, Lahtela J, et al
     Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival.
     J Diabetes Complications. 2024;38:108719.
     PubMed     Abstract available
     
     
     February 2024
236. MATSUURA S, Nagata S, Shibazaki K, Uchida R, et al
     Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes.
     J Diabetes Complications. 2024;38:108717.
     PubMed     Abstract available
     
     
     December 2023
237. PATOULIAS D, Eid AH, Rizzo M
     Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus.
     J Diabetes Complications. 2023;37:108630.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.